Cargando…

Plegia to walking: AHSCBMT in severe NMOSD relapse

OBJECTIVES: Neuromyelitis optica is a devastating, relapsing, inflammatory, autoimmune disorder characterised in large part by attacks of optic neuritis and transverse myelitis causing blindness and plegia in many patients. Eighty-three per cent of patients with transverse myelitic attacks and 67% o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlisle, Nicola, Hari, Parameswaran, Brod, Staley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903183/ https://www.ncbi.nlm.nih.gov/pubmed/33681798 http://dx.doi.org/10.1136/bmjno-2020-000073

Ejemplares similares

Imagine There Is No Plegia. Mental Motor Imagery Difficulties in Patients with Traumatic Spinal Cord Injury
por: Thomschewski, Aljoscha, et al.
Publicado: (2017)

Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
por: Pittock, Sean J, et al.
Publicado: (2021)

Preliminary results of posterior contralateral cervical 7 nerve transposition in the treatment of upper limb plegia after a stroke
por: Guan, Jingyu, et al.
Publicado: (2020)

Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status
por: S, Mariotto, et al.
Publicado: (2017)

Lupus and NMOSD: The Blending of Humoral Autoimmunity
por: Ochi, Maria Goretti S., et al.
Publicado: (2020)

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
por: Stastna, Dominika, et al.
Publicado: (2022)

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
por: Khalilidehkordi, Elham, et al.
Publicado: (2020)

Therapy challenges for NMOSD in a patient with HIV
por: Engels, Daniel, et al.
Publicado: (2023)

Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)

Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)

Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort
por: Dauby, Solène, et al.
Publicado: (2021)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

Contemporary management challenges in seropositive NMOSD
por: Costello, Fiona, et al.
Publicado: (2022)

Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
por: Esmaeili, Sara, et al.
Publicado: (2021)

Walking on Visual Illusions
por: Dickson, Greig, et al.
Publicado: (2021)

Plasmapheresis for NMOSD: Not a Rescue Therapy Anymore!?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation
por: Thapa, Bicky, et al.
Publicado: (2021)

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
por: Lin, Liuyu, et al.
Publicado: (2022)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
por: Fragoso, Diego Cardoso, et al.
Publicado: (2023)

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
por: Brod, Staley A.
Publicado: (2020)

Ingested Type I Interferon—State of the Art as Treatment for Autoimmunity Part 2
por: Brod, Staley A.
Publicado: (2010)

High-throughput investigation of molecular and cellular biomarkers in NMOSD
por: Yandamuri, Soumya S., et al.
Publicado: (2020)

Cognitive impairment in NMOSD—More questions than answers
por: Czarnecka, Dominika, et al.
Publicado: (2020)

Blood pressure and body fat percent in women with NMOSD
por: Chen, Xiaohong, et al.
Publicado: (2019)

NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis
por: Szewczyk, Anna K., et al.
Publicado: (2022)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD
por: Shosha, Eslam, et al.
Publicado: (2018)

Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews
por: Capobianco, Marco, et al.
Publicado: (2023)

Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients
por: He, Qianyi, et al.
Publicado: (2019)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Autonomous exoskeleton reduces metabolic cost of human walking
por: Mooney, Luke M, et al.
Publicado: (2014)

Metabolic cost and mechanics of walking in women with fibromyalgia syndrome
por: MacPhee, Renée S, et al.
Publicado: (2013)

Sjögren’s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) – a case report and review of literature
por: Jayarangaiah, Apoorva, et al.
Publicado: (2014)

Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSD
por: Rotstein, Dalia L
Publicado: (2022)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
por: Yan, Yaping, et al.
Publicado: (2016)

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD
por: Cook, Lawrence J., et al.
Publicado: (2019)

Impaired Meningeal Lymphatic Flow in NMOSD Patients With Acute Attack
por: Wang, Xinxin, et al.
Publicado: (2021)

Enlarged perivascular spaces, neuroinflammation and neurological dysfunction in NMOSD patients
por: Yao, Xiao-Ying, et al.
Publicado: (2022)

The patient journey with NMOSD: From initial diagnosis to chronic condition
por: Delgado-Garcia, Guillermo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hlbceso2qh3h4ce7m7j7197oap